Therapy News and Research

RSS

Repair defect in neurons hints at possible therapy for preventing ALS

Houston Methodist researchers have discovered a repair defect in nerve cells that send messages to the brain, opening the door to a possible therapy for preventing or slowing down ALS.

1 Nov 2018

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

The Indiana University Philanthropic Venture Fund, which provides capital to faculty, students, alumni and staff at all IU campuses to help them further develop their research and innovations into startup companies, has committed to invest $500,000 in Indianapolis-based NERx Biosciences Inc. as part of a $2.2 million bridge round.

1 Nov 2018

UC Scientist receives NIH grant for developing new malaria therapeutic strategies

A scientist at the University of California, Riverside, who researches the malaria-causing parasite, Plasmodium falciparum, is the principal investigator, or PI, on two grants from the National Institutes of Health, or NIH, totaling nearly $6.6 million. Funding from each grant is for five years.

1 Nov 2018

Study: Wide and varied body of evidence support best practices in palliative care

A study commissioned to help guide revisions of best practices in providing palliative care finds that there is a wide and varied body of evidence to support such clinical practice guidelines.

1 Nov 2018

UA scientists aim to identify drug targets for rare pediatric cancer

Rhabdomyosarcoma is a rare cancer of the skeletal muscle that primarily affects pediatric patients. After diagnosis, about 3 out of 4 patients are cured with standard treatment. Survival rates drop to 17 percent if the disease comes back (recurs) and to 30 percent if it spreads (metastasizes).

1 Nov 2018

Researchers discover biomarker for most common type of heart failure

A team led by a Cedars-Sinai physician-scientist has discovered a biomarker--a protein found in the blood--for the most common type of heart failure, a new study published today in JAMA Cardiology shows.

1 Nov 2018

NIH funding will allow four pediatric health systems to study causes of growth disorders

The National Institutes of Health awards Andrew Dauber, M.D., MMSc, the chief of endocrinology at Children's National Health System, a five-year grant that will allow four pediatric health systems to compile and study clinical and genetic markers of severe pediatric growth disorders.

31 Oct 2018

New insight on quality control in the cellular immune system

Robert Tampé, Director of the Institute of Biochemistry at Goethe University, has received € 1.5 million from the German Research Foundation for a Reinhart Koselleck project.

31 Oct 2018

Two-cells-in-one combo therapy shows promise in strengthening leukemia treatment

A cancer therapy based on fusing two types of cells into a single unit shows promise in strengthening existing treatments for acute myeloid leukemia. The approach joins blood platelets that carry cancer drugs with stem cells that guide the platelets into bone marrow where leukemia begins.

31 Oct 2018

Pain sensitization linked to increased risk for persistent knee pain

Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis, according to a new study by researchers from the Université de Montréal School of Rehabilitation and Hôpital Maisonneuve Rosemont Research Centre in collaboration with researchers at Boston University School of Medicine.

31 Oct 2018

Goethe University plays important role in rare disease research

Patients with rare diseases often go through a long history of suffering before finally receiving an accurate diagnosis.

31 Oct 2018

New software may enable early detection of arteriosclerosis

Arteriosclerosis is one of the widespread diseases. If the blood is no longer pumped properly through the veins, a heart attack or stroke may be the consequence. In most cases, the disease is only diagnosed at an advanced stage.

31 Oct 2018

Texas A&M study identifies new brain region involved in inhibiting fear

A study conducted at Texas A&M University has identified a new area in the brain involved in inhibiting fear, a discovery that holds potential for clinical interventions in patients with psychiatric diseases such as post-traumatic stress disorder.

31 Oct 2018

Study finds pain sensitization as key risk factor for persistent knee pain in osteoarthritis

Becoming more sensitive to pain, or pain sensitization, is an important risk factor for developing persistent knee pain in osteoarthritis, according to a new study by researchers at Université de Montréal and its affiliated Maisonneuve Rosemont Hospital Research Centre, in collaboration with researchers at Boston University.

31 Oct 2018

Study shows how machinery within immune system activates T cells to attack cancer

In just a few years, CAR T-cell and other adoptive T-cell therapies have emerged as among the most promising forms of cancer immunotherapy.

31 Oct 2018

CRISPR genome editing has foreseeable implications for plastic and reconstructive surgery

The CRISPR genome editing technique promises to be a "transformative leap" in genetic engineering and therapy, affecting almost every area of medicine.

31 Oct 2018

First shared Swiss platform to promote regenerative medicine launched in Bern

Regenerative Medicine is one of the fastest growing sectors in biomedical research – replacing diseased cells, tissues or organs.

31 Oct 2018

World’s first vaccine against coeliac disease to be tested in Australia

US-based pharmaceutical company ImmusanT, after worldwide trials, is all set to start clinical trials of a new vaccine against coeliac disease at the Royal Melbourne Hospital Clinical Trials Centre in Melbourne. This will be followed by trials to be held at Adelaide, Brisbane, Perth, Mackay and Sunshine Coast say the sources.

31 Oct 2018

Researchers examine immune responses to CRISPR-Cas9 gene editing system

The CRISPR-Cas9 gene editing system has been generating excitement within the field of gene therapy, inspiring hopes of molecular tools capable of treating genetic diseases.

30 Oct 2018

Using genome editing to prevent sudden cardiac death

Each year, at least 3 million people worldwide die of sudden cardiac death. In the U.S., this number reaches up to 450,000 people.

30 Oct 2018

Therapy News and Research

Repair defect in neurons hints at possible therapy for preventing ALS

IU Philanthropic Venture Fund commits to invest $500,000 to NERx Biosciences company

UC Scientist receives NIH grant for developing new malaria therapeutic strategies

Study: Wide and varied body of evidence support best practices in palliative care

UA scientists aim to identify drug targets for rare pediatric cancer

Researchers discover biomarker for most common type of heart failure

NIH funding will allow four pediatric health systems to study causes of growth disorders

New insight on quality control in the cellular immune system

Two-cells-in-one combo therapy shows promise in strengthening leukemia treatment

Pain sensitization linked to increased risk for persistent knee pain

Goethe University plays important role in rare disease research

New software may enable early detection of arteriosclerosis

Texas A&M study identifies new brain region involved in inhibiting fear

Study finds pain sensitization as key risk factor for persistent knee pain in osteoarthritis

Study shows how machinery within immune system activates T cells to attack cancer

CRISPR genome editing has foreseeable implications for plastic and reconstructive surgery

First shared Swiss platform to promote regenerative medicine launched in Bern

World’s first vaccine against coeliac disease to be tested in Australia

Researchers examine immune responses to CRISPR-Cas9 gene editing system

Using genome editing to prevent sudden cardiac death

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News